semaglutide 1 week results Blog | Garland Sachse Wylie Murphy Medical clinic Semiglutide (Wegovy) in Overweight Non-Diabetic

In particular, the SURMOUNT-1 trial demonstrated that patients on tirzepatide experienced up to 22.5% weight loss , while semaglutide users typically averaged around 15% at the highest dose

Neurological Disorders Conditions like stroke, Alzheimers disease, Parkinsons disease, and multiple sclerosis can affect the nerves that control taste

The INFORM survey used a validated 22-question Food Noise Questionnaire, giving the findings more methodological weight than typical patient anecdote, though researchers appropriately note that larger randomized controlled trials are still needed to confirm the full scope of these effects

Stay Hydrated : Drink at least 64 ounces (about 2 liters) of water daily